PPD, Bend Research in Services Alliance

PPD, Inc. and Bend Research have entered into a collaboration in the areas of formulation development, analytical testing and clinical supplies manufacturing to provide pharmaceutical and biotechnology companies a full range of chemistry, manufacturing and controls (CMC) development services.

The two companies will refer potential business opportunities to one another in the areas of compound characterization, particle engineering, formulation development, clinical trial material (CTM) manufacturing, analytical development, stability programs, and GMP release and quality control testing. A key area of collaboration will be inhalation formulation development and particle engineering for drug therapies. The two companies also plan to collaborate on opportunities that involve services provided by each company and to work together on client bids and projects.

Bend Research’s formulation development and particle engineering expertise will strengthen PPD’s ability to provide clients full-service CMC product development solutions. Bend Research clients will have access to PPD’s facilities in Madison, WI, Wayne, PA, and Athlone, Ireland.

“We continue to see strong global demand for our analytical laboratory services,” said Magdalena Mejillano, Ph.D., vice president of cGMP lab services for PPD. “The agreement with Bend Research allows us to expand our preformulation and formulation development expertise, enhance our strong CMC laboratory capabilities and provide clients a more complete offering for small and large molecule testing.”

Rod Ray, Ph.D., Bend Research’s president and chief executive officer, added, “Working with PPD strengthens our position as a leading drug formulation resource for pharmaceutical companies. This collaboration with PPD offers a competitive advantage to biopharmaceutical companies looking for innovative drug delivery technologies.”